The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 14, 2014

Filed:

Aug. 25, 2006
Applicants:

Ilya Trakht, Bronx, NY (US);

Gavreel Kalantarov, Fort Lee, NJ (US);

Inventors:

Ilya Trakht, Bronx, NY (US);

Gavreel Kalantarov, Fort Lee, NJ (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/0781 (2010.01); C12N 5/09 (2010.01); C12N 5/10 (2006.01); C07K 16/00 (2006.01); C12N 5/16 (2006.01);
U.S. Cl.
CPC ...
C12N 5/163 (2013.01); C07K 16/00 (2013.01); C07K 2317/21 (2013.01);
Abstract

Certain aspects of the present invention are directed to new fully human fusion partner cell lines called human Karyochi cells, and to methods for making them. Human Karyochi cells are then fused with human antibody-secreting lymphoid cells to make fully human hybridomas called Karyochi-based hybridomas, which likewise secrete fully human monoclonal antibodies. Human Karyochi cells are made by isolating a donor nucleus that is substantially free of cytoplasm from either a first malignant B-lymphocyte cell line or a normal B-lymphocyte, and transferring the donor nucleus into the cytoplasm of a recipient cell from a second T- or B-lymphoid cell line. With time the nuclei synchronize and fuse to form the chimeric Karyochi fusion partner cell line. Nuclear transfer can be accomplished using intra-cytosolic nucleus injection or by impact-induced nucleus administration.


Find Patent Forward Citations

Loading…